This inventor holds 1 USPTO granted patent. Top assignee: Korea Basic Science Institute. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Innovator Sang-Yeop Lee: Pioneering Diagnosis of Overactive Bladder Disease
Introduction: Sang-Yeop Lee, an accomplished inventor based in Daejeon, South Korea, has made a significant impact in the field of biomedical research. His innovative work has led to the development of a pioneering biomarker aimed at diagnosing overactive bladder (OAB) disease. With a focus on advancing medical diagnostics, Sang-Yeop's contributions are integral to enhancing patient care and treatment options.
Latest Patents: Sang-Yeop Lee holds a patent titled "Biomarker for diagnosing overactive bladder disease and screening method of therapeutic agents using the same." This invention is pivotal for diagnosing OAB and involves a method that utilizes specific protein markers released into urine. By enabling a non-invasive and rapid diagnosis, his biomarker can effectively distinguish between patients suffering from OAB and those from normal populations. Moreover, the invention also focuses on screening therapeutic agents that normalize the expression and activity of these markers for more effective treatment options.
Career Highlights: Currently, Sang-Yeop Lee is associated with the Korea Basic Science Institute, where he continues to push the boundaries of research in biomedical science. His work contributes to the growing field of diagnostic tools that are crucial for the efficient management of bladder conditions.
Collaborations: Throughout his career, Sang-Yeop has collaborated with talented coworkers, including Gun Hwan Kim and Edmond Changkyun Park. Together, they share a commitment to advancing their field and exploring innovative solutions for healthcare challenges.
Conclusion: Sang-Yeop Lee exemplifies the spirit of innovation within the scientific community. Through his groundbreaking patent on a biomarker for overactive bladder disease, he lays the groundwork for not only improved diagnostic methods but also the potential for more effective therapeutic agents. His dedication to collaboration and research underscores the importance of teamwork in fostering advancements in medical technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
